Area of research
Surgery · Inorganic Chemistry
Research interest
Research focused on Escitalopram and Tauroursodeoxycholic acid, with related work in Transcriptome, Gene knockdown, Spinal cord injury. Notable publications include 'Tauroursodeoxycholic acid alleviates secondary injury in the spinal cord via up-regulation of CIBZ gene', 'Early Enhancement of Neuroplasticity Index, the Ratio of Serum Brain-Derived Neurotrophic Factor Level to HAMD-24 Score, in Predicting the Long-Term Antidepressant Efficacy', and 'Transcriptome profiling reveals the role of ZBTB38 knock-down in human neuroblastoma'.
Brain network predictors of changes in symptoms and serum BDNF following antidepressant treatment with escitalopram and Yueju Pill in major depressive disorder: a randomised, double‐blind, placebo‐controlled pilot study
Early Enhancement of Neuroplasticity Index, the Ratio of Serum Brain-Derived Neurotrophic Factor Level to HAMD-24 Score, in Predicting the Long-Term Antidepressant Efficacy
Transcriptome profiling reveals the role of ZBTB38 knock-down in human neuroblastoma
ZBTB38, a novel regulator of autophagy initiation targeted by RB1CC1/FIP200 in spinal cord injury
Tauroursodeoxycholic acid alleviates secondary injury in the spinal cord via up-regulation of CIBZ gene